Research Analysts Issue Forecasts for PRQR FY2025 Earnings
ProQR Therapeutics (NASDAQ:PRQR – Free Report) – Equities research analysts at Cantor Fitzgerald cut their FY2025 earnings estimates for ProQR Therapeutics in a note issued to investors on Monday, May 12th. Cantor Fitzgerald analyst S. Seedhouse now anticipates that the biopharmaceutical company will post earnings per share of ($0.43) for the year, down from their […]
ProQR Therapeutics (NASDAQ:PRQR – Free Report) – Equities research analysts at Cantor Fitzgerald cut their FY2025 earnings estimates for ProQR Therapeutics in a note issued to investors on Monday, May 12th. Cantor Fitzgerald analyst S. Seedhouse now anticipates that the biopharmaceutical company will post earnings per share of ($0.43) for the year, down from their […]
